Athena Diagnostics

Athena Diagnostics is a clinical diagnostic service testing laboratory specializing in neurology, endocrinology, and nephrology. As a leader in genetic testing and personalized medicine, Athena Diagnostics' mission is to improve patients' lives by providing physicians with the best diagnostic services. Athena Diagnostics is a leader in diagnostic testing for neurological disorders and offers innovative testing methods for Alzheimer's disease, muscular dystrophy, and other neuromuscular and developmental disorders. It is committed to providing neurologists and other physicians and specialists with insights that can improve patients' health conditions, offering the most comprehensive testing menu and intellectual property portfolio for neurological, endocrine, and kidney diseases through more than 400 diagnostic tests. Athena Diagnostics was founded in 1988 as Genica Pharmaceuticals and has undergone several changes in control: acquired by Athena Neuroscience in 1995; acquired by Elan Pharmaceuticals in 1996; acquired by Behrman Capital in 2002; acquired by Fisher Scientific in 2006, which was later renamed Thermo Fisher; and acquired by Quest Diagnostics in 2011.